Physician profile
Prabhav Tella
NPI 1013942358
$5,128.89
in general payments reported to CMS, 2019-2025
23 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $180 · 2021: $727 · 2022: $2,097 · 2023: $1,492 · 2024: $435 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,399 · Travel and Lodging: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,399.17 |
| Travel and Lodging | $726.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,558.34 | 2020-2023 | Senza |
| Relievant Medsystems, INC. | $1,049.26 | 2023 | Intracept |
| Vertos Medical, INC. | $606.22 | 2021-2023 | Mild Device Kit |
| Boston Scientific Corporation | $533.29 | 2021-2024 | Intracept |
| Medtronic, INC. | $288.01 | 2021-2025 | Inceptiv, Accurian |
| Electronic Waveform Lab, INC. | $174.58 | 2022 | |
| Abbvie INC. | $146.27 | 2022-2024 | Qulipta, Botox |
| Medtronic USA, INC. | $134.94 | 2020 | |
| Grt US Holding, INC. | $131.59 | 2021-2022 | |
| Stryker Corporation | $131.00 | 2024 | Omnicurve, Optablate |
| Protega Pharmaceutials INC | $48.12 | 2022-2023 | Roxybond |
| Curonix LLC | $42.99 | 2023-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Stimwave Technologies Incorporated | $39.66 | 2020-2022 | |
| Scilex Pharmaceuticals INC. | $36.73 | 2022 | |
| Abbott Laboratories | $36.18 | 2024 | Proclaim |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $30.16 | 2025 | |
| Ibsa Pharma INC. | $24.14 | 2021 | |
| Lundbeck LLC | $21.45 | 2025 | Vyepti |
| Tersera Therapeutics LLC | $21.33 | 2025 | Prialt |
| Hikma Pharmaceuticals USA | $20.24 | 2022 | |
| Spinal Simplicity, LLC | $19.32 | 2022 | |
| Si-Bone, INC. | $19.25 | 2022 | |
| Pfizer INC. | $15.82 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prabhav Tella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.